Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Advanced patent CN102336633B enables high-selectivity 2,4-dicumylphenol production. Reduces wastewater and energy costs for reliable supply chain partners.
Patent CN115043787B reveals metal-free photocatalytic route. Offers significant cost reduction and supply chain reliability for high-purity oxazole intermediate manufacturing globally.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN102219665B details a green Cu-SBA-15 catalyzed oxidation for Vitamin E precursors, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Patent CN119143745A reveals ozone oxidation for metazopyr. Enhances purity and reduces environmental waste for agrochemical supply chains.
Patent CN104099305A reveals stable CgKR1 mutants for Clopidogrel intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing.
Patent CN114605458A details a novel Rh-catalyzed C-C bond activation method for high-purity chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN114644614B reveals a novel 3-step route to L-nicotine with >99.9% ee. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Patent CN103788050A details a water-based green catalytic route for 2-amino-4H-chromenes using biodegradable ionic liquids, offering significant cost and supply chain advantages.
Patent CN116143673A reveals a novel Ni-Cu oxide catalyzed route for diphenyl sulfide, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
One-step synthesis patent analysis for high-purity iridium catalysts reducing cost and lead time for pharmaceutical intermediates manufacturing and ensuring supply chain reliability.
Novel method for clarithromycin intermediate using lactam salts. Reduces waste, improves safety. Reliable supplier for API intermediates.
Patent CN103086845A reveals a high-yield L-menthol route using ZnBr2/NaY zeolite, offering superior stereoselectivity and cost-effective manufacturing for global supply chains.
Discover the novel cobalt-catalyzed reductive amination route for Vonoprazan Fumarate. Enhanced yield, simplified process, and cost-effective manufacturing for global supply chains.
Novel visible-light method for quinoline intermediates. Reduces cost and improves supply chain reliability for anti-tumor drug development.
Novel catalytic method for 3,4,5-Trifluoro phenol ensures high purity and cost efficiency for electronic and pharma applications.